Oral etoposide in the treatment of cutaneous large-cell lymphomas. A preliminary report of four cases.
The favourable results of oral etoposide as single-agent therapy in four patients with a cutaneous lymphoma other than mycosis fungoides are reported. In all cases other chemotherapeutic options were limited because of prior chemotherapy or the age of the patients. Therapy with etoposide resulted in an initial complete remission in all patients, and was associated with minimal side-effects.
Rijlaarsdam
J U
JU
Department of Dermatology, Free University Hospital, Amsterdam, The Netherlands.
Huijgens
P C
PC
Beljaards
R C
RC
Bakels
V
V
Willemze
R
R
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
D005047:Etoposide